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doi:10.1016/j.ejvs.2010.04.016Abstract Objectives: The aim of this study was to determine the mid-term patency and the
clinical outcome after stenting of chronic occluded caval and iliofemoral venous segments.
Design: Observational study.
Material/methods: During the period 2000 and 2009, 2400 patients with chronic venous insuf-
ficiency (CVI) were evaluated, and 34 with chronic venous occlusions after deep venous throm-
bosis (DVT) were selected for endovascular treatment. The median age was 41 (range 15e63)
years, and 19 were female. The following investigations were undertaken: colour duplex ultra-
sound (CDU), ascending venography (AV), venous occlusion plethysmography (VOP), venous
pressure gradient (VPG) and CT venography or trans-femoral/popliteal venography. The major
symptoms were venous claudication, oedema, pain and ulcer. All patients were treated by
stenting occluded segments. Self-expanding stents were deployed in 22 iliofemoral, nine iliac
and one caval-iliac-femoral. Twenty-one procedures required stenting across the inguinal liga-
ment.
Results: Primary recanalisation was accomplished in 32/34 (94%). The median follow-up was 33
months (1e96) with clinical examination, CDU and VOP. Two-year primary patency was 14/21
(67%), primary-assisted patency 16/21(76%), and secondary patency was 19/21 (90%). Venous
claudication and oedema resolved in those successfully recanalised. Four of the seven ulcers
healed.
Conclusion: Stenting to treat venous claudication, oedema and recurrent venous ulcer caused
by post-thrombotic chronic venous occlusions has positive clinical outcome and good mid-term
patency.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.3033093; fax: þ47 22225648.
(A. Rosales).
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Stenting Post-thrombotic Chronic Venous Occlusions 235The standard treatment for deep venous thrombosis (DVT)
is anti-coagulation with low molecular weight heparin fol-
lowed by oral warfarin.1 The fact that removal of thrombus
is not one of the effects accomplished by anti-coagulation
may have a severe impact in the long-term disability caused
by DVT. Post-thrombotic syndrome (PTS) characterised by
reflux and/or obstruction will develop in as many as 40% of
patients suffering a DVT. Venous claudication and/or leg
ulceration are serious clinical consequences experienced by
at least 15% of patients developing PTS.2e4 The pattern of
spontaneous recanalisation after DVT varies according to
the affected anatomical segment as shown by colour duplex
ultrasound (CDU) studies. While recanalisation occurs in up
to 90% of the femoro-popliteal veins after one year, this is
rarely the case (<5%) after iliofemoral thrombosis.5
Persistent, chronic venous outflow obstruction in the ilio-
femoral veins leads to the development of venous claudi-
cation in about 43% of these patients.6 Surgical treatment
of chronic venous obstruction has produced variable results
with very few available reports of long-term follow-up.7,8
The development of percutaneous endovascular tech-
niques has made possible the recanalisation and stenting of
chronic venous occlusions with successful clinical outcomes
and low morbidity.9,10
The long-term consequences of DVT occurred in terms of
the development of PTS. The latter represents a reduction
in quality of life, and it incurs large costs to society if this
condition remains untreated. There are few reports in the
literature analysing the effect of endovascular treatment in
patients with severe symptoms due to venous outflow post-
thrombotic chronic occlusions.9e13
The aim of this study was to assess the mid-term patency
and clinical outcome after recanalisation and stenting of




initially evaluated with colour duplex ultrasound (CDU) and
ambulatory venous pressure measurement. Fifty-nine
patientswith severe symptoms including venous claudication,
oedema, pain and leg ulcer suggestive of venous outflow
impairment were further investigated with ascending venog-
raphy (AV), venous occlusion plethysmography (VOP), venous
pressure gradient (VPG) and CT venography or trans-femoral/
popliteal venography. The severity of these symptoms
rendered thesepatients incapable of functioning atwork and/Table 1 This series was grouped according to the CEAP clinic
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a High ambulatory venous pressure levels median 72 mmHg (64e72)
b Abnormal values of venous occlusion plethysmography.
c Abnormal values of venous pressure gradient.
d Venous clinical severity score, median and range.or in other physical activities, representing a clear indication
to attempt endovascular treatment. Twenty-five patients
were foundunavailable for endovascular treatment due to the
extension of the post-thrombotic occlusion to the popliteal
level that precluded adequate restoration of venous blood
flow.Theother34patientshadchronicvenousocclusionsafter
DVT with open popliteal and distal femoral veins, and were
chosen for treatment. This group constitutes the patients
included in our study, whowere then categorised according to
the CEAP (clinicaleetiologicaleanatomicalepathophysio-
logical) classification for chronic venous insufficiency.14 The
severity of the symptoms was assessed using the venous clin-
ical severity score (VCSS)15 (Table 1).
Themedian patient agewas 41 (range 15e63) years, and19
werewomen.The timeelapsed following thepreviousepisode
of DVT varied widely with a median of 108 (range 9e420)
months. Seventeen patients (50%) had a thrombophilia (APC
resistance, protein C or S deficiency and homocysteinaemia).
Themajor symptomswere venous claudication in 27 patients,
oedema in 24, pain in 21 and leg ulcer in seven. Eighteenout of
34 (53%) patients were on sick leave, and 6/34 (18%) patients
on welfare at the time of diagnosis.
In addition to venous outflow obstruction, reflux was
detected in the femoro-popliteal veins along with high
levels of ambulatory venous pressure (AVP) in 18/34 (53%)
patients. Air plethysmography and/or VPG measurement
were positive in only 17/34 (50%) patients.
All 34 patients were planned for treatment using endo-
vascular techniques by recanalisation and stenting. In two
cases, recanalisation was not possible. In three cases,
complementary open surgery was required during the same
procedure: two A-V fistulas, and one vein plasty.
Self-expanding stents (Wall) were placed in the iliac-
femoral segment in 22 cases, in the iliac segment alone in
nine cases, and in one case, in the cava-iliac and femoral
segment. Twenty-one procedures required stenting across
the inguinal ligament to secure adequate inflow.
Anti-coagulation was administered pre-, per- and post-oper-
atively, first, using low molecular weight heparin (LMWH), dal-
teparin 100 IE/kg/twice daily, and then using warfarin. Patients
with a proven thrombophilia received lifelong anti-coagulation.
The others were evaluated individually in conjunction with
a haematologist, according to the other risk factors.
Investigations
Colour duplex ultrasound (CDU) was used to evaluate axial
reflux in the different anatomical segments of each venousal classification. The pathophysiological features are shown
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Figure 1 Puncture of the popliteal vein is performed with
ultrasound guidance.
236 A. Rosales et al.system. Morphological post-thrombotic changes of the vein,
such as, wall thickening, trabeculae and the lack of colour
or Doppler signal were also assessed.
AVP measurement was used to assess the global venous
reflux, which is a function of the veno-muscular pump and
the severity of venous hypertension. AVP provides infor-
mation about a pressure drop with ambulation (a measure
of the venous pump function), ambulatory pressure and
recovery time. Both CDU and AVP are described in the
detail in our previous publications.16,17
To evaluate the haemodynamic significance of a post-
thrombotic vein occlusion, two additional investigations
were performed:
VOP was performed to exclude persistent venous outflow
obstruction by using an air plethysmograph (MacroLab,Figure 2 Baseline venography showing occlusion of the left
iliac and femoral veins, with pelvic, paravertebral and supra-
pubic collaterals.E. Stranden). In the recumbent position, venous occlusion
and recording cuffs were applied proximally to the patella
and at the calf, respectively. An occlusive cuff pressure of
50 mmHg was maintained during 1 min. This permits unin-
hibited arterial flow into the limb, while the venous outflow
is compromised, resulting in an increased leg volume. On
decompression of the thigh cuff, the leg volume decreases
rapidly when the venous outflow is normal. In case of the
presence of a functional venous obstruction, the leg volume
will decrease slowly.
VPG was obtained by comparing venous pressure
measurements before and after a reactive hyperaemia test
of the lower extremity. An inflatable tourniquet was
applied to the thigh, and venous pressure was recorded in
a superficial leg vein. With the patient in supine position,
a basal measurement was done. The thigh tourniquet was
then inflated to 300 mmHg of pressure and sustained for
3 min. After releasing the tourniquet, reactive hyperaemia
increases arterial flow and thus venous outflow. A venous
pressure increase above 8 mmHg may indicate an outflow
obstruction.
Endovascular and Surgical Procedure
The procedures were performed in a hybrid suite, under
general anaesthesia. Access was gained by ultrasound-
guided puncture of the popliteal vein (nZ 19), femoral
vein (nZ 13). (Fig. 1). In two cases, the access was
combined with jugular puncture, in one, due to vena
cava involvement, and in the other, to be able to
catheterise the profunda femoral vein. Once access was
established, baseline venography was performed to
determine the extent of the post-thrombotic occlusion,
both cranially and caudally (Fig. 2). By using hydrophilic
guide wires (Terumo), the occluded segment was
passed through. Pre-dilatation angioplasty was carriedFigure 3 Pre-dilatation is recommended. This picture illus-
trates how resilient a stenosis/occlusion can be in a post-
thrombotic vein and the obvious need for stenting.
Stenting Post-thrombotic Chronic Venous Occlusions 237out before large diameter (16e12 mm) self-expanding
stents (Wallstent) were deployed (Fig. 3). After
implantation, the stents were dilated with appropriate
size balloons. Cranially, the stent was placed well into
the vena cava (1e2 cm) and caudally enough to secure
inflow (Fig. 4). Crossing the inguinal ligament was often
necessary to secure adequate inflow as described by
other authors (Figs. 5 and 6). Successful recanalisationFigure 4 Large diameter, self-expanding stents should be
chosen. Tapering from 16 to 12 mm. The stents are deployed
well into the vena cava (1e2 cm) to avoid re-stenosis.
Figure 5 It is essential to secure inflow even if it means
crossing the inguinal ligament with a stent.was defined as the free flow of contrast medium through
a stented venous segment emptying into the vena cava
without collaterals. Slow flow and/or post-thrombotic
changes caudally were criteria to consider the
construction of an arterio-venous fistulae.
Pneumatic sequential pumps were used post-operatively
(Lympha Press) to promote flow through the stented
segments of the vein.18
Follow-up
Patients were followed-up after 3, 6 and 12 months and
yearly, thereafter. The resolution/recurrence of clinical
signs and symptoms was recorded by using the venous
disability score (VCSS) and related to the patient’s ability to
function at work/home. CDU was performed to visualise the
stent segment recording flow and looking for morphological
changes suggesting stenosis (>50% diameter reduction)
with Doppler and spectral analysis. If the findings of CDU
were inconclusive, venography was carried on. VOP was
performed routinely in all patients looking for early hae-
modynamic signs of re-obstruction.
Figure 6 It is essential to secure inflow even if it means
crossing the inguinal ligament with a stent.
238 A. Rosales et al.Data Collection and Statistical Analysis
This is an observational study of patients with post-throm-
botic chronic venous occlusions resulting in severe disability
due to venous claudication, combined with leg ulcer and
oedema, and treated endovascularly. Clinical outcomes and
mid-term patency after this form of treatment were
assessed. Data were collected in a prospective database by
using FileMaker Pro software. The statistical analysis was
done by using a commercially available statistical program
(Graph Pad Prism). Data were considered to be non-para-
metrically distributed and the median with range have beenTable 2 This table summarises the results and shows a clea





6 7 7used as descriptors. A ManneWhitney U-test was used to
determine significance in clinical outcome. Survival analysis
with the KaplaneMeier, log rank test was to extract actuarial
survival curves to be able to compare primary, primary-
assisted and secondary patency rates.
The end points were recurrence of symptoms and/or
stent occlusion confirmed by CDU.Results
Successful recanalisation was accomplished in 32/34 (94%)
of cases during which no major complication arose. Two
occlusions occurred within a month. Venous claudication,
oedema and pain resolved in those successfully recanal-
ised. Four ulcers healed after 3 months (Table 2). The
clinical improvement recorded by using the VCSS score was
statistically significant for both C III and C VI groups
(pZ 0.0001 and pZ 0.002, respectively). Reconstructive
deep venous surgery in the form of venous valve trans-
plantation was needed at a later stage to accomplish ulcer
healing in three. Despite a clear clinical picture of venous
claudication preoperatively, haemodynamic evidence of
outflow impairment by using VOP and VPG was shown in
only 18/34 patients.
Post-operatively haemodynamic improvement in
outflow (VOP and VPG), after successful stenting, was
recorded in only four of these 17. Reflux and high AVP
persisted unchanged in 16 patients after successful
stenting.
The median follow-up was 33 months (1e96) with clinical
examination, CDU and VOP. VCSS was assessed at 3 months
follow-up to establish the clinical outcome. Symptom recur-
rence occurred in 13 patients and was investigated with both
CDU and trans-popliteal venography. In two cases, a signifi-
cant stenosis compromising the inflow was discovered. New
stentingwasperformed inboth, andtheconstructionofanA-V
fistula was necessary in one. In six occlusions, catheter-based
thrombolysis (CBT) and further stenting was performed with
construction of anA-V fistula in three. In five other occlusions,
re-interventionwasconsiderednot tobe indicateddue topoor
inflow conditions (Table 3).
The 2-year primary patency rate was 14/21 (67%),
primary-assisted patency of 16/21 (76%) and secondary
patency was 19/21 (90%).
By comparing KaplaneMeier survival curve analysis, we
attempted to identify factors that could influence patency.
Stents deployed above the inguinal ligament showed
a better primary patency, but no difference was recorded
on the secondary patency. In those patients with throm-
bophilia, the patency was no different when compared with
those with normal coagulation (Figs. 7e9).r improvement when comparing the VCSS before and after
uccessful recanalisation.
Reflux Pre-VCSS Post-VCSS
9 9 (5e12) 1 (0e11)
7 21 (18e29) 7 (6e14)
Table 3 Recurrence of symptoms occurred in 13 patients.
In two re-stenosis was detected and treated. The other 11
events represented occlusions which were treated in only 6
patients.
Events (13) Procedures (8)
Re-stenosis (2) Stent, stentþ A-V
fistula
Occlusions (3) CBTþ stent
Occlusions (3) CBTþ stentþ A-V
fistula
Occlusions (5) None
Figure 8 PPZ primary patency. SPZ secondary patency.
Survival curves comparing patency of stents deployed above
and below the inguinal ligament (pZ 0.0063, Log rank test).
Stenting Post-thrombotic Chronic Venous Occlusions 239Discussion
Chronic venous obstruction, after DVT, can be the cause of
major disability and yet, it is an under-diagnosed condition,
based on the prevalence and the anatomical distribution of
DVT. According to the results in the present study, venous
claudication and leg ulcer caused by chronic post-throm-
botic total venous occlusions in the femoro-iliocaval
segments can be effectively treated by percutaneous
recanalisation and stenting. The preoperative duration of
the occlusion process does not seem to influence the
technical feasibility for recanalisation.
The use of the VCSS score showed significant clinical
improvement after successful recanalisation and stenting;
and we may remind the reader that the maximal score
varies according to which CEAP clinical class it refers to; for
C3 it is 12, while for C5 it is 30.
Our 2-year primary patency was 67%, primary-assisted
patency of 76% and secondary patency was 90%. This is
somewhat better than the one reported by Raju et al. in
2002, in a very similar series regarding aetiology and total
occlusions.13 Other articles published address both stenosis
(non-occlusive lesions) and occlusions; furthermore, there
is a mixture of aetiology. Hartung et al. mid-term patency
compares with ours, but this series included only 10/44
post-thrombotic cases.11 In the remarkable material pub-
lished by Neglen et al. in 2007, 45% of 982 lesions wereFigure 7 Survival analysis (KaplaneMeier) curves for
primary, assisted primary and secondary patency after recan-
alisation and stenting of total venous occlusions (pZ 0.0340,
Log rank test).post-thrombotic, but only 6% were occlusions,9 and yet,
their patency is comparable with ours at 24 months. Ko¨lbel
et al. published in 2009 results of a series where 66% was
post-thrombotic with primary patency of 67%, assisted
primary patency 75% and secondary patency 79%, at 2
years.12
The size of our series may represent a certain lack of
power, but when we look at the number of equivalent cases
(total occlusions after DVT) in other publications and
convert it to cases per year, the figure varies from 1 to 6 per
year. We report 3.7 per year.
We found, as have other authors, that the haemody-
namic tests for venous obstruction that are currently
available lack accuracy and sensitivity, making difficult
a correlation with clinical symptoms. Therefore, imaging
techniques and clinical symptoms may constitute the main
parameters to indicate treatment and to evaluate outcome
during the follow-up period as of today, but this is an area
that deserves further research.
Crossing the inguinal ligament (2/3 of our patients) is
necessary in many cases and even though it may seem nega-
tively to influence the primary patency, it is placing stents
distally that yields to a better secondary patency19 (Fig. 8).
Surveillance of these patients after treatment is impor-
tant to detect re-stenosis. Symptom recurrence seems to
be a reliable sign that warrants prompt CDU examination. InFigure 9 PPZ primary patency. SPZ secondary patency.
Survival curves showing that thrombophilia patients did not
reach a significant different patency (pZ 0.1340, Log rank
test).
240 A. Rosales et al.cases of re-occlusion, immediate catheter directed
thrombolysis and re-stenting is possible and may be
durable, as suggested with our secondary patency rate. A
good clinical outcome, combined with little morbidity and
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